Eucalyptus Amplifolia and Corymbia Torelliana in the Southeastern USA: Genetic Improvement and Potential Uses

Eucalyptus amplifolia and Corymbia torelliana genetic improvement has been conducted in the lower southeastern USA by UF and collaborators since 1980. The collective accomplishments in genetic resources and potential commercial uses are summarized. For example, fast-growing, freeze-resilient E. amplifolia seeds are provided by 1st and 2nd generation seedling seed orchards (SSO) and a 2nd generation clonal seed orchard (CSO), while C. torelliana seed are available from 1st and 2nd generation SSOs. Breeding values (BV) have been developed for guiding the deployment of improved genotypes. Collaborative genetic improvement of these species is ongoing, including testing E. amplifolia in 11 countries and development of hybrid clones. Short Rotation Woody Crop (SRWC) systems may increase productivity and extend uses beyond conventional mulchwood to products such as medium density fiberboard (MDF), biochar, and energywood, while other possible applications include honey production, windbreaks, dendroremediation, and carbon sequestration. C. torelliana may be paired with E. grandis in two-row windbreaks to maximum windbreak effectiveness and may sequester as much carbon as E. grandis.

Design Improvements of a Silicon Photonic ROADM (Project Report CIAN2-1-Y4)

This was a project “Silicon Photonics Device Manufacturing and Test” under the re-organized Thrust 2 “Subsystem Integration and Silicon Nanophotonics” of an NSF-funded Center. This is a report of the 2nd generation ROADM (reconfigurable optical add drop multiplexer) device made using silicon photonics, including passive and doped silicon waveguides and metalization.

Peran Mahasiswa Kampus Mengajar 2 Sebagai “Agent Of Change dan Social Control”

Students are the assets of a nation because students are a group of people trained in various fields of knowledge and skills. State Junior High School 2 Tanggulangin s one of the target schools selected by the author and Ministry of Education and Culture as the place for the Kampus Mengajar 2nd Generation as the student change agent of the education program created by us, among them the implementation of literacy learning activities and student numeration aimed at improving the understanding of literacy and student numeration. Social control is a tool to control himself or society. In this case, the society underneath is the entire State Junior High School 2 Tanggulangin and students as the main object of Kampus Mengajar 2nd Generation activities

Plasmapheresis: Is it a potential alternative treatment for chronic urticaria?

Background Chronic urticaria is a common disease. Plasmapheresis is an alternative treatment that can be appropriate for patients who are resistant to treatment with 2nd generation antihistamines or for whom treatment with omalizumab is unsuitable. Objective To investigate the effect of plasmapheresis treatment in chronic urticaria. Methods A retrospective analysis was performed based on the data of 98 patients suffering from refractory chronic urticaria who received plasmapheresis as an alternative treatment in Vilnius University’s Hospital Santaros Clinics from 2000 to 2020. The efficiency of the treatment was evaluated by clinical judgment. Results 58.2% of the patients exhibited a complete or significant response; of these, 37.8% had temporary relief of symptoms and 20.4% achieved disease remission; 41.8% showed no response to the plasmapheresis. Men (34.8%) had a tendency to achieve disease remission more often than women (16%) (p < 0.05). One patient did not finish the plasmapheresis treatment due to the symptoms’ exacerbation and treatment with omalizumab was initiated. Conclusion Plasmapheresis is a safe and effective alternative treatment when traditional treatment is unavailable or does not relieve symptoms completely. Our data showed that plasmapheresis was effective in more than half of our patients.

EGFR-D770>GY and Other Rare EGFR Exon 20 Insertion Mutations with a G770 Equivalence Are Sensitive to Dacomitinib or Afatinib and Responsive to EGFR Exon 20 Insertion Mutant-Active Inhibitors in Preclinical Models and Clinical Scenarios

Epidermal growth factor receptor (EGFR) exon 20 insertion mutations account for a tenth of all EGFR mutations in lung cancers. An important unmet clinical need is the identification of EGFR exon 20 insertion mutants that can respond to multiple classes of approved EGFR-TKIs. We sought to characterize variants involving EGFR-D770 to EGFR-G770 position equivalence changes that structurally allow for response to irreversible 2nd generation EGFR-TKIs. Our group used preclinical models of EGFR exon 20 insertion mutations to probe representative 1st (erlotinib), 2nd (afatinib, dacomitinib), 3rd generation (osimertinib) and EGFR exon 20 insertion mutant-active (poziotinib, mobocertinib) TKIs; we also queried the available clinical literature plus our institutional database to enumerate clinical outcomes. EGFR-D770>GY and other EGFR insertions with a G770 equivalence were identified at a frequency of 3.96% in separate cohorts of EGFR exon 20 insertion mutated lung cancer (n = 429). Cells driven by EGFR-D770>GY were insensitive to erlotinib and osimertinib, displayed sensitivity to poziotinib and dacomitinib and were uniquely sensitive to afatinib and dacomitinib in comparison with other more typical EGFR exon 20 insertion mutations using proliferation and biochemical assays. Clinical cases with EGFR-G770 equivalence from the literature and our center mirrored the preclinical data, with radiographic responses and clinical benefits restricted to afatinib, dacomitinib, poziotinib and mobocertinib, but not to erlotinib or osimertinib. Although they are rare, at <4% of all exon 20 insertion mutations, EGFR-G770 equivalence exon 20 insertion mutations are sensitive to approved 2nd generation EGFR TKIs and EGFR exon 20 insertion mutant-active TKIs (mobocertinib and poziotinib). EGFR-D770>GY and other insertions with a G770 equivalence join EGFR-A763_Y764insFQEA as exon 20 insertion mutationsresponsive to approved EGFR TKIs beyond mobocertinib; this data should be considered for clinical care, genomic profiling reports and clinical trial elaboration.

COMPARATIVE STUDY OF THE EFFICIENCY IN THE PRODUCTION OF SECOND GENERATION ALCOHOL

The use of biofuels, such as ethanol, is seen as a viable alternative, due to the growing need for alternative clean energy sources, research on the subject has been intensified, especially when it comes to fuels, the search for a reduction in energy consumption. The rate of gases responsible for the greenhouse effect, therefore, makes it necessary to replace fossil fuels with clean and renewable fuels. The 2nd. Generation (E2G), compared to 1st Ethanol. Generation (E1G), has shown significant environmental and social gains, as it is produced from waste, uses less natural resources and energy. Within this context, this work aims to analyze the efficiency and economic viability of the production of second generation alcohol – E2G. Based on an exploratory bibliographic research, in the following databases, academic google and web of Science, in articles published on the topic discussed here, from 2010 onwards. second-generation alcohol with first-generation alcohol, to discover its economic viability and production efficiency.

1H NMR Analysis of the Metathesis Reaction between 1-Hexene and (E)-Anethole Using Grubbs 2nd Generation Catalyst: Effect of Reaction Conditions on (E)-1-(4-Methoxyphenyl)-1-hexene Formation and Decomposition

The metathesis of 1-hexene and (E)-anethole in the presence of Grubbs 2nd generation catalyst was monitored by in situ 1H NMR spectroscopy at different temperatures (15 °C, 25 °C, and 45 °C) and anethole mol fractions (XAnethole ≈ 0.17, 0.29, 0.5, 0.71, 0.83). Time traces confirmed the instantaneous formation of (E)-1-(4-methoxyphenyl)-1-hexene, the cross-metathesis product. A maximum concentration of (E)-1-(4-methoxyphenyl)-1-hexene is reached fairly fast (the time depending on the reaction conditions), and this is followed by a decrease in the concentration of (E)-1-(4-methoxyphenyl)-1-hexene due to secondary metathesis. The maximum concentration of (E)-1-(4-methoxyphenyl)-1-hexene was more dependent on the XAnethole than the temperature. The highest TOF (3.46 min−1) was obtained for the reaction where XAnethole was 0.16 at 45 °C. The highest concentration of the cross-metathesis product was however achieved after 6 min with an anethole mol fraction of 0.84 at 25 °C. A preliminary kinetic study indicated that the secondary metathesis reaction followed first order kinetics.